Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines-Reference-Cited by-同舟云学术

Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines

Published:2020-09 Issue:39 Volume:38 Page:6075-6077
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Forman Rebecca,Anderson Michael,Jit Mark^ORCID,Mossialos Elias

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference16 articles.

1. World Health Organization. Draft landscape of COVID-19 candidate vaccines; 2020.

2. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial;Folegatti;Lancet (London, England),2020

3. CEPI. CEPI gets €140 million funding boost from Germany while expanding coronavirus vaccine search. CEPI 2020. https://cepi.net/news_cepi/cepi-gets-e140-million-funding-boost-from-germany-while-expanding-coronavirus-vaccine-search/ (accessed March 16, 2020).

4. Bill Gates to help fund coronavirus-vaccine development;Calfas;Wall Str J,2020

5. CEPI. Netherlands and Switzerland join the search for COVID-19 vaccines. CEPI 2020. https://cepi.net/news_cepi/netherlands-and-switzerland-join-the-search-for-covid-19-vaccines/ [accessed April 25, 2020].

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outer Membrane Vesicles: A Challenging Yet Promising Platform for COVID-19 Vaccines;COVID-19 Vaccines - Current State and Perspectives;2023-02-22

2. Prioritizing the Factors Affect in Covid-19 Vaccines, a Fuzzy-AHP Approach;Lecture Notes in Mechanical Engineering;2023

3. Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non–COVID-19 Indications, 2020-2021;JAMA Network Open;2022-08-16

4. Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis;Frontiers in Public Health;2022-07-22

5. Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal–fetal transference of antibodies in mice;Pathogens and Disease;2022